The impact of safety concerns on antipsychotic use

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2010年 / 1286卷 / 1期
关键词：
Dementia; Nursing Home; Safety Concern; Elderly Person; Atypical Antipsychotic;
D O I：
10.2165/00128415-201012860-00005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [41] Safety concerns for off-label Osurnia use in cats
    McFadzean, Harriet
    Strugnell, Ben
    Collins, Cam
    Jones, Alwyn
    Phipps, L. Paul
    Johnson, Nicholas
    VETERINARY RECORD, 2021, 189 (05) : 208 - 208
  • [42] Ephedra use under fire - Deaths amplify safety concerns
    Schnirring, L
    PHYSICIAN AND SPORTSMEDICINE, 2003, 31 (04): : 13 - 15
  • [43] Prescriptions of Antipsychotics in Younger and Older Geriatric Patients with Polypharmacy, Their Safety, and the Impact of a Pharmaceutical-Medical Dialogue on Antipsychotic Use
    Gebauer, Eva-Maria
    Lukas, Albert
    BIOMEDICINES, 2022, 10 (12)
  • [44] Antipsychotic use in pregnancy in France: is Reproductive Safety different according to the indication?
    Montastruc, F.
    Hurault-Delarue, C.
    Pariente, A.
    Lacroix, I.
    Montastruc, J. L.
    Begaud, B.
    Damase-Michel, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 53 - 54
  • [45] ANTIPSYCHOTIC USE IN MEDICAID-INSURED YOUTH: SAFETY AND POLICY IMPLICATIONS
    Burcu, M.
    Ibe, A.
    Safer, D. J.
    Zito, J. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S133 - S134
  • [46] Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses
    McConville, BJ
    Sorter, MT
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 : 20 - 29
  • [47] Impact of antipsychotic medication use on functioning in people with diabetes.
    Ellis, SL
    McCollum, M
    Lu, L
    Sullivan, PW
    PHARMACOTHERAPY, 2005, 25 (03): : 460 - 460
  • [48] Impact of FDA Black Box Advisory on Antipsychotic Medication Use
    Dorsey, E. Ray
    Rabbani, Atonu
    Gallagher, Sarah A.
    Conti, Rena M.
    Alexander, G. Caleb
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (01) : 96 - 103
  • [49] IMPACT OF FDA BLACK BOX ADVISORY ON ANTIPSYCHOTIC MEDICATION USE
    Dorsey, R.
    Rabbani, A.
    Gallagher, S.
    Conti, R.
    Alexander, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (04) : 675 - 675
  • [50] The impact of weight gain associated with atypical antipsychotic use in schizophrenia
    Chue, P
    Cheung, R
    ACTA NEUROPSYCHIATRICA, 2004, 16 (03): : 113 - 123
12345